Great Lakes Health Program in Rwanda_Phasing out (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/great-lakes-health-program-in-rwanda-phasing-out
Background The prevalence of chronic malnutrition (i.e. stunting) among children under five in Rwanda is very high; stunting rates across the country average 38% for children under five and exceed 50%
Backstopping Mandate Health Focal Point, Health Network and Global Health, Phase XIX (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/backstopping-mandate-health-focal-point-health-network-and-global-health-phase-xix
The objective of the backstopping mandate (BSM)is to support SDC‘s core competence in health and provide advisory services to SDC‘s Global Programme Health (GPH), its Health Focal Points, and to the m
Movement rates of African malaria vectors and their implications in models of vector control interventions (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/movement-rates-of-african-malaria-vectors-and-their-implications-in-models-of-vector-control-interventions
Movement rates of African malaria vectors and their implications in models of vector control interventions.
Evaluation of the Papua New Guinea National Malaria Control Program, 2015-2017 (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/evaluation-of-the-papua-new-guinea-national-malaria-control-program-2015-2017
The Papua New Guinea National Department of Health (NDOH) is receiving financial support from the Global Fund to Fight AIDS, Tuberculosis and Malaria for the implementation of its malaria control prog
Reactive Case Detection in Zanzibar: Effectiveness and Cost (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/reactive-case-detection-in-zanzibar-effectiveness-and-cost
Over the past 15 years, Zanzibar (United Republic of Tanzania) has achieved a substantial reduction in the burden of malaria by distributing insecticide treated mosquito nets, indoor residual spraying
Preclinical profiling of virosomally formulated B-cell epitope mimetics derived from the novel key malaria vaccine candidates CyRPA and RH5 (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/preclinical-profiling-of-virosomally-formulated-b-cell-epitope-mimetics-derived-from-the-novel-key-malaria-vaccine-candidates-cyrpa-and-rh5
Clinical testing of two components for a synthetic peptide-based virosomal malaria vaccine has yielded promising results, encouraging the search for additional components for inclusion in a final mult